Lupin Limited (LUPIN.NS) Financial Analysis & Valuation | Quarter Chart

Lupin Limited (LUPIN.NS)

LUPIN.NS
Price: $24.48
Fair Value: 🔒
🔒score
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatric... more
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded a... more
Description Shares
Market Cap$11.18BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOVinita D. Gupta
IPO Date2001-09-10CAGR0.15%
Employees19,210Websitewww.lupin.com
Div. Yield0.04%Payout Ratio
Buy Back YieldTotal Yield0.04%
LUPIN.NS chart loading...
Fundamentals Technicals
Enterprise Value$886.01BP/E Ratio22
Forward P/E21.76PEG Ratio0.21
P/S Ratio891.19P/B Ratio1182.48
P/CF RatioP/FCF Ratio
EPS$1.11EPS Growth 1Y63.24%
EPS Growth 3YEPS Growth 5Y
Revenue Growth 1Y12.4%Gross Margin0.69%
Operating Margin0.26%Profit Margin0.16%
ROE0.22%ROA
ROCECurrent Ratio
Quick RatioCash Ratio
Debt/EquityInterest Coverage18.75
Altman Z ScorePiotroski Score3